Are statins a remedy for all seasons?

Journal of Hepatology

Volumn 62, Issue 1, 2016, Pages 8-10

  Negro, Francesco ^a  

^a University Hospital   (Switzerland)

Author keywords

Hepatitis C virus; Hepatocellular carcinoma; Liver fibrosis; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BODY MASS; DISEASE COURSE; EDITORIAL; FATTY LIVER; FIBROGENESIS; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MAINTENANCE THERAPY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PLEIOTROPY; FEMALE; HEPATITIS C, CHRONIC; LIVER; LIVER CIRRHOSIS; MALE; PATHOLOGY;

FEMALE; HEPATITIS C, CHRONIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIVER; LIVER CIRRHOSIS; MALE;

EID: 84918772332     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.09.018     Document Type: Editorial

References (21)

1. B. Hajarizadeh, J. Grebely, and G.J. Dore Epidemiology and natural history of HCV infection Nat Rev Gastroenterol Hepatol 10 2013 553 562
2. Rüeger S, Bochud PY, Dufour JF, Muellhaupt B, Semela D, Heim MH, et al. Impact of common risk factors of fibrosis progression in chronic hepatitis C. Gut [in press].
3. R. D'Ambrosio, A. Aghemo, M.G. Rumi, G. Ronchi, M.F. Donato, and V. Paradis A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis Hepatology 56 2012 532 543
4. D. Schuppan, and M. Pinzani Anti-fibrotic therapy: lost in translation? J Hepatol 56 2012 S66 S74
5. K.L. Watts, E.M. Sampson, G.S. Schultz, and M.A. Spiteri Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts Am J Respir Cell Mol Biol 32 2005 290 300
6. R. Reddy, G. Chahoud, and J.L. Mehta Modulation of cardiovascular remodeling with statins: fact or fiction? Curr Vasc Pharmacol 3 2005 69 79
7. J. Trebicka, M. Hennenberg, M. Odenthal, K. Shir, S. Klein, and M. Granzow Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells J Hepatol 53 2010 702 712
8. T. Miyaki, S. Nojiri, N. Shinkai, A. Kusakabe, K. Matsuura, and E. Iio Pitavastatin inhibits hepatic steatosis and fibrosis in non-Alcoholic steatohepatitis model rats Hepatol Res 41 2011 375 385
9. Z.M. Younossi, M.J. Reyes, A. Mishra, R. Mehta, and L. Henry Systematic review with meta-Analysis: non-Alcoholic steatohepatitis - A case for personalised treatment based on pathogenic targets Aliment Pharmacol Ther 39 2014 3 14
10. T.G. Simon, L.Y. King, H. Zheng, and R.T. Chung Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C J Hepatol 62 2015 18 23
11. A.M. Di Bisceglie, M.L. Shiffman, G.T. Everson, K.L. Lindsay, J.E. Everhart, and E.C. Wright Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon N Engl J Med 359 2008 2429 2441
12. C.G. Mihos, A.M. Pineda, and O. Santana Cardiovascular effects of statins, beyond lipid-lowering properties Pharmacol Res 88C 2014 12 19
13. J.W. Clendening, and L.Z. Penn Targeting tumor cell metabolism with statins Oncogene 31 2012 4967 4978
14. S.F. Nielsen, B.G. Nordestgaard, and S.E. Bojesen Statin use and reduced cancer-related mortality N Engl J Med 367 2012 1792 1802
15. Y.T. Tsan, C.H. Lee, W.C. Ho, M.H. Lin, J.D. Wang, and P.C. Chen Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection J Clin Oncol 31 2013 1514 1521
16. Y.T. Tsan, C.H. Lee, J.D. Wang, and P.C. Chen Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection J Clin Oncol 30 2012 623 630
17. S. Tanaka, Y. Fukumoto, K. Nochioka, T. Minami, S. Kudo, and N. Shiba Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation Arterioscler Thromb Vasc Biol 33 2013 1591 1600
18. B. Verpaalen, J. Neyts, and L. Delang Are statins a viable option for the treatment of infections with the hepatitis C virus? Antiviral Res 105 2014 92 99
19. M.W. Russo, J.H. Hoofnagle, J. Gu, R.J. Fontana, H. Barnhart, and D.E. Kleiner Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network Hepatology 60 2014 679 686
20. D.H. Katz, S.S. Intwala, and N.J. Stone Addressing statin adverse effects in the clinic: the 5 Ms J Cardiovasc Pharmacol Ther 2014 [Epub ahead of print]
21. J.G. Abraldes, A. Albillos, R. Banares, J. Turnes, R. Gonzalez, and J.C. Garcia-Pagan Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial Gastroenterology 136 2009 1651 1658